Log in to download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Holder | DMF No. | Subject | Submission Date | Status | Type | GDUFA DMF Review | GDUFA Review Date | GDUFA Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30/12/2025 | Nektar Therapeutics |
U.S.A |
NEKTAR THERAPEUTICS | 23484 | N-HYDROXYSUCCINIMIDYL ESTER OF BIS (METHOXYPOLY(ETHYLENE GLYCOL) MW 20,000) MODIFIED LYSINE | 2010-05-07 | Inactive | II | N/A |
